← FDA DRUG APPROVALS

FDA BLA · BLA761432

ENFLONSIA

clesrovimab

Sponsor: MERCK SHARP DOHME

APPLICATION
BLA761432
TYPE
BLA
ORIGINAL APPROVAL
2025-06-09
LATEST ACTION
2025-06-09
ROUTE
INTRAMUSCULAR, SOLUTION
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription

Products

ENFLONSIAPrescription
CLESROVIMAB-CFOR 105MG/0.7ML · INJECTION · SOLUTION

Approval history

2025-06-09Type 1 - New Molecular Entity · Original · priorityLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →